Mortality and morbidity in suspected XXXX in relation to ambulance transport.

@entity1 @entity712 @entity1188 @entity3303 @entity2224 @entity158 @entity583
In 681 @entity1 admitted to the coronary care unit (CCU) at Sahlgrenska hospital between 1 May 1983 and 31 May 1984, due to suspected @entity583 ( @entity583 ), the hospital mortality and morbidity were related to whether the @entity1 were transferred to hospital by ambulance or not. In the ambulance group @entity583 developed in 48% (during the first 3 days in hospital) compared with 41% in the non-ambulance group (P = 0.10). The overall mortality rate was 10.4% in the ambulance group versus 3.8% in the non-ambulance group (P = 0.001). Corresponding figures for @entity583 @entity1 were 19.3% versus 9.1% (P = 0.02). In all, @entity1 referred by ambulance had larger @entity1188 according to maximum serum enzyme activity and a higher incidence of @entity712 . Similar findings were observed when @entity583 @entity1 were analysed separately. On the other hand, the incidence of @entity2224 , requirement for @entity3303 , and the course of @entity158 was fairly similar in the two groups. In a multivariate analysis, @entity1188 size was the major independent predictor for early mortality rate. We conclude that @entity1 who call for an ambulance due to suspected @entity583 appear to have a different early mortality and morbidity pattern compared to those who do not. The most obvious observation was a higher early mortality. These @entity1 therefore might be the most suitable candidates for early intervention studies.
